A compound which is a casein kinase inhibitor
By providing casein kinase inhibitor compounds with specific structures, the problem of insufficient casein kinase inhibitors in the prior art has been solved, and effective treatment of circadian rhythm disorders has been achieved.
CN116888126BActive Publication Date: 2026-03-17GRITSCI BIOPHARM CO LTD
11 Cites 0 Cited by
Patent Information
- Application Number
- CN202180083438.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-12-15
- Filing Date
- 2021-12-14
- Publication Date
- 2026-03-17
- Estimated Expiration
- 2041-12-14
AI Technical Summary
Technical Problem
The lack of effective casein kinase inhibitors in current technologies makes it difficult to effectively treat diseases related to circadian rhythm disorders such as depression, seasonal affective disorder, and metabolic disorders.
Method used
A series of compounds with specific structures are provided as effective inhibitors of casein kinase, including pharmaceutically acceptable salts, prodrugs, or solvates thereof, for inhibiting the activity of casein kinase.
Benefits of technology
These compounds can effectively inhibit casein kinase, preventing and treating diseases associated with circadian rhythm disorders such as mood disorders, sleep disorders, and circadian rhythm disorders, especially depression and bipolar disorder.
✦ Generated by Eureka AI based on patent content.
Abstract
This disclosure provides casein kinase inhibitors or pharmaceutically acceptable salts thereof. Corresponding compositions, treatment methods, and intermediates are also provided.
Need to check novelty before this filing date? Find Prior Art